Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation

Overview of attention for article published in Stroke, December 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 26 news outlets
twitter: 49 X users

facebook: 4 Facebook pages
guideline: 3 clinical guideline sources

Readers on

mendeley: 74 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 5 public wall posts from 4 users.

Stroke AHA/ ASA, 23 Jan 2017

Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation http://bit.ly/2jH…

Association Tunisienne d'Etude et de Recherche Sur L'Athérosclérose (ATERA), 06 Dec 2016

Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation http://bit.ly/2g1…

Stroke AHA/ ASA, 06 Dec 2016

Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation http://bit.ly/2g1…

Neurology Today, 02 Dec 2016

Resuming anticoagulation therapy after a major bleeding event was associated with a higher likelihood of stroke-free survival…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity, including 1 additional Facebook posts.